Shareprice
14 Jun 2024

Press & news

FluoGuide develops surgical solutions that is expected to reduce suffering for the patient and increases the likelihood of cure as well as reducing costs for the health care system.

New - New exchange: Nasdaq First North

FluoGuide is moving from Spotlight to Nasdaq First North. Shareholders are strongly encouraged to make sure they will be able to freely trade their shares in the future.

FluoGuide appoints new CFO

News


August 31, 2022

Copenhagen, Denmark, 31 August 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) has today appointed Henrik Hang as Chief Financial Officer (“CFO”). Henrik Hang has substantial experience as CFO from international companies to biotech company listed on Nasdaq First North Growth Market, Stockholm

Henrik Hang comes most recently from the role as CFO at Cyxone AB (publ). Henrik Hang has a degree in finance from University of Linné, Sweden and will be part of FluoGuide´s management team. Henrik Hang will start at FluoGuide on the 15th of November 2022.

Henrik Hang will replace the current CFO Henrik Moltke, who wished to step down as CFO to devote more time on board work and family. Henrik Moltke will continue as senior advisor for the company with special focus on investor relations and communication.

Morten Albrechtsen, CEO says” I am very glad to welcome Henrik as our new CFO that will give a strong financial management from public companies, I am also happy that we can continue draw on Henrik Moltke’s broad experience within IR as senior advisor”.